
About Skisen Labs Private Limited
Data last updated:
Skisen Labs Private Limited was a private limited company based in Vadodara, Gujarat, India, operated as a subsidiary of Sun Pharmaceutical Industries Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 13 January 2005.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2005PTC133239.
The company had an authorised share capital of ₹17 Cr and a paid-up capital of ₹16.36 Cr. It was led by directors including Prince Kalarickal Elias (Whole-Time Director) and Kedar Nath Senapati (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Sun Pharma Advanced Research Centre (Sparc) Tandalja, Vadodara, Gujarat, India – 390012.
The company has 2 deals on record (1 acquisition, 1 secondary share transfer); the latest was in November 2015.
The last known website on record is sunpharma.com.
Company details
CIN history
Skisen Labs has one previous CIN (Corporate Identification Number): U73100MH2005PTC150606. The current CIN is U73100GJ2005PTC133239, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100GJ2005PTC133239 | Current |
| U73100MH2005PTC150606 | Previous |
Contact details
Skisen Labs Private Limited's registered office is in Vadodara, Gujarat. Its website is sunpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSun Pharma Advanced Research Centre (Sparc) Tandalja, Vadodara, Gujarat, India – 390012
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Skisen Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Skisen Labs Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Skisen Labs Private Limited, buy the company report.
Board of directors of Skisen Labs Private Limited
Skisen Labs has 3 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prince Kalarickal Elias | Whole-Time Director | 01 Aug 2021 | 5 Years 3 Months | As last reported |
| Sanjay Jerry Also directs: Asawari Petro Services LLP, Accumen QC Automation Solutions Private Limited, Shanghvi Universal Private Limited and 2 more | Director | 31 Oct 2020 | 6 Years 0 Months | As last reported |
| Kedar Nath Senapati | Whole-Time Director | 29 Jan 2024 | 2 Years 9 Months | As last reported |
Auditor
Skisen Labs Private Limited is audited by S R B C & CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2023 | 324982E/E300003 |
Shareholding
The shareholding of Skisen Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Skisen Labs Private Limited, buy the company report.
Deals & funding
Skisen Labs Private Limited has 2 deals on record (1 acquisition, 1 secondary share transfer); the latest was in November 2015.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2015 | Acquisition | ₹16.35 Cr | Buyer: Sun Pharmaceutical Industries Limited |
| Sep 2012 | Secondary share transfer | Undisclosed | Buyer: Sun Pharmaceutical Industries Limited & Sailesh T Desai, Sun Pharmaceutical Industries Limited & Dilip S Shanhvi, Sun Pharmaceutical Industries Limited & Ashok I Bhuta Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Skisen Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Skisen Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Skisen Labs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Skisen Labs Private Limited has 15 board changes on record since 2013: 3 appointments and 12 cessations. The latest: Kedar Nath Senapati was appointed as Whole-Time Director on 29 Jan 2024.
6 earlier events are in the company report.
Frequently asked questions
Skisen Labs has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Skisen Labs was a private limited company based in Vadodara, Gujarat, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 13 January 2005 and is registered under CIN U73100GJ2005PTC133239. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Skisen Labs was incorporated on 13 January 2005. It is registered with the Registrar of Companies, Ahmedabad.
Skisen Labs had 3 directors:
- Prince Kalarickal Elias - Whole-Time Director
- Kedar Nath Senapati - Whole-Time Director
- Sanjay Jerry - Director
The CIN (Corporate Identification Number) of Skisen Labs is U73100GJ2005PTC133239. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Skisen Labs is at Sun Pharma Advanced Research Centre Sparc Tandalja, Vadodara, Gujarat, India – 390012.
Skisen Labs can be reached through the website sunpharma.com. Its registered office is in Vadodara, Gujarat, India.
The latest financial statements of Skisen Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
Skisen Labs operated in the pharma industry, in the pharma contract r and d segment.
Skisen Labs has 2 deals on record (1 acquisition, 1 secondary share transfer); the latest was in November 2015.

